LUIS
BUJANDA FERNÁNDEZ DE PIÉROLA
Mayo Clinic
Rochester, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Mayo Clinic (25)
2024
-
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
Journal of Crohn's and Colitis, Vol. 18, Núm. 3, pp. 349-359
2022
-
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease
Nature Reviews Gastroenterology and Hepatology, Vol. 19, Núm. 9, pp. 585-604
2021
-
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders
Nature Genetics, Vol. 53, Núm. 11, pp. 1543-1552
-
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models
Journal of Hepatology, Vol. 74, Núm. 2, pp. 394-406
2020
-
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
Liver International, Vol. 40, Núm. 7, pp. 1670-1685
2018
-
Faecal microbiota composition associates with abdominal pain in the general population
Gut
-
Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome
Gastroenterology, Vol. 155, Núm. 1, pp. 168-179
-
Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients
Clinical Gastroenterology and Hepatology
-
MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
Hepatology, Vol. 67, Núm. 4, pp. 1420-1440
2017
-
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma
Journal of Hepatology, Vol. 67, Núm. 1, pp. 72-83
-
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Hepatology, Vol. 66, Núm. 4, pp. 1125-1143
-
TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M
Gut, Vol. 66, Núm. 9, pp. 1725-1727
2016
-
Immunotherapy in colorectal cancer: What have we learned so far?
Clinica Chimica Acta, Vol. 460, pp. 78-87
2015
-
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease
Journal of Hepatology, Vol. 63, Núm. 4, pp. 952-961
2014
-
Clinical relevance of KRAS mutations in codon 13: Where are we?
Cancer Letters
-
Corrigendum to Clinical relevance of KRAS mutations in codon 13: Where are we? [Cancer Lett. 343 (1 (2013) 1-5]
Cancer Letters
-
Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases
Gut, Vol. 63, Núm. 10, pp. 1658-1667
2013
-
Alcohol consumption on pancreatic diseases
World Journal of Gastroenterology, Vol. 19, Núm. 5, pp. 638-647
-
Molecular markers in pancreatic cancer diagnosis
Clinica Chimica Acta, Vol. 418, pp. 22-29
-
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
Oncogenesis, Vol. 2